Evolving role of positron emission tomography (PET) in urological malignancy

Sebastian Mafeld; Nikhil Vasdev; Amit Patel; Tamir Ali; Timothy Lane; Gregory Boustead; Andrew C Thorpe; James M Adshead; Philip Haslam

doi:10.1111/bju.12988

Evolving role of positron emission tomography (PET) in urological malignancy

BJU Int. 2015 Oct;116(4):538-45. doi: 10.1111/bju.12988. Epub 2015 May 25.

Authors

Sebastian Mafeld¹, Nikhil Vasdev^{2

3}, Amit Patel³, Tamir Ali¹, Timothy Lane³, Gregory Boustead³, Andrew C Thorpe², James M Adshead³, Philip Haslam¹

Affiliations

¹ Department of Radiology, Freeman Hospital, Newcastle upon Tyne, UK.
² Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK.
³ Hertfordshire and South Bedfordshire Robotic Urological Cancer Centre, Department of Urology, Lister Hospital, Stevenage, UK.

PMID: 25410715
DOI: 10.1111/bju.12988

Abstract

We present a review on the increasing indications for the use of positron emission tomography (PET) in uro-oncology. In this review we describe the details of the different types of PET scans, indications for requesting PET scans in specific urological malignancy and the interpretation of the results.

Keywords: indication; positron emission tomography (PET); urological malignancy.

Publication types

Review

MeSH terms

Fluorodeoxyglucose F18
Gallium Radioisotopes
Humans
Positron-Emission Tomography*
Urologic Neoplasms / diagnostic imaging*
Urologic Neoplasms / pathology

Substances

Gallium Radioisotopes
Fluorodeoxyglucose F18